Innoviva

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.

CEO

Pavel Raifeld

CEOPavel Raifeld

Employees

—

Employees—

Headquarters

Burlingame, California

HeadquartersBurlingame, California

Founded

1996

Founded1996

Employees

—

Employees—

INVA Key Statistics

Market cap

949.04M

Market cap949.04M

Price-Earnings ratio

6.94

Price-Earnings ratio6.94

Dividend yield

—

Dividend yield—

Average volume

644.34K

Average volume644.34K

High today

$15.16

High today$15.16

Low today

$14.95

Low today$14.95

Open price

$15.08

Open price$15.08

Volume

77.45K

Volume77.45K

52 Week high

$16.87

52 Week high$16.87

52 Week low

$11.37

52 Week low$11.37

INVA News

TipRanks 1d

Innoviva: trial data for uncomplicated gonorrhea treatment presented at ESCMI

Innoviva Specialty Therapeutics , a subsidiary of Innoviva announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an or...

Yahoo Finance 3d

Should Weakness in Innoviva, Inc.'s Stock Be Seen As A Sign That Market Will Correct The Share ... - Yahoo Finance

It is hard to get excited after looking at Innoviva's (NASDAQ:INVA) recent performance, when its stock has declined 10% over the past three months. But if you p...